News
The Lymphoma Research Foundation (LRF), the nation’s largest non-profit organization dedicated exclusively to funding innovative lymphoma research and serving the lymphoma community, today named Christine Ryan, MD, as the first recipient of the Kanti R. Rai Clinical Scholar Award for her work in the ongoing study of Richter’s Transformation (RT), which is a severe progression of chronic lymphocytic leukemia (CLL) in a B-cell lymphoma. The Kanti R. Rai Scholar Award was first created in 2022 and was established in recognition of Dr. Rai’s global leadership in the field of lymphoma/CLL research and his commitment to LRF’s mission.
The U.S. Food and Drug Administration Approves Glofitamab-gxbm (Columvi) for Diffuse Large B-Cell Lymphoma
On June 15, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved…
Read the Latest Issue of Pulse: Spring 2023
Dear Friends of LRF, Since its inception, one of the Lymphoma Research Foundation’s (LRF) guiding…
Where Are They Now? Martin Rivas, PhD
Where Are They Now? Martin Rivas, PhD When did you become interested in the study…
Following a Passion to Improve Patients’ Lives
Following a Passion to Improve Patients’ Lives Lindsay M. Morton, PhD, Director of the Radiation…
Story of Hope: Scott Fink
Story of Hope: Scott Fink Scott Fink is a born-and-bred New Yorker, married 20 years…
Meet the 2023 Career Development Award, Postdoctoral Fellowship, and Follicular Lymphoma Priority Research Grantees
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.
The U.S. Food and Drug Administration Approves Epcoritamab-bysp (Epkinly) for Diffuse Large B-Cell Lymphoma
On May 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved…
Lymphoma Research Foundation Funds 27 New Grants Supporting the Next Generation of Lymphoma Scientists
Lymphoma Research Foundation Awards More Than $5.4 Million in Lymphoma Research Grants New York, NY…
The U.S. Food and Drug Administration Approves Polatuzumab Vedotin-piiq (Polivy) for Diffuse Large B-Cell Lymphoma
On April 19, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved polatuzumab…